Top Markets
Coin of the day
LAUNXP Biomedical Co., Ltd LAUNXP Biomedical Co., Ltd

LAUNXP Biomedical Co., Ltd

6876
Rank in Stocks #28267
LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical... LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical treatments for various types of cancer. Their product line includes therapies designed to combat tumor growth and inhibit cell proliferation, notably utilizing advanced platforms such as virus-like nanoparticles and other nanoparticle-based drug delivery systems. The company was established on September 24, 2015, and its primary corporate operations are based in Taichung, Taiwan.
Share Price
$0.39748785
Last synced: 2026-08-19
Market Cap
$27.51M
Change (1 day)
-4.21%
Change (1 year)
-48.76%
Country
TW
Trade LAUNXP Biomedical Co., Ltd (6876)

Category

Operating Margin for LAUNXP Biomedical Co., Ltd (6876)
Operating Margin as of 2026 TTM: 0.00%
According to LAUNXP Biomedical Co., Ltd latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for LAUNXP Biomedical Co., Ltd from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
-149.01% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.